iVeena Awarded NEI-SBIR Grant For Progressive Myopia Drug Candidate IVMED-85
26 Oct 2023 //
BUSINESSWIRE
Burns & Levinson Represents iVeena in Licensing Agreement with Glaukos Corp
29 Aug 2022 //
PRNEWSWIRE
Glaukos Corporation Announces Second Quarter 2022 Financial Results
03 Aug 2022 //
BUSINESSWIRE
iVeena Announces Successful Completion of Pre-IND Meeting with FDA
10 Nov 2021 //
YAHOOFINANCE